CM
Capstan Medical
Santa Cruz, United States
Founded 2020
About Capstan Medical
Capstan Medical develops robotic-assisted catheter systems for structural heart valve replacement. Combines surgical robotics with catheter-based technology for less invasive mitral and tricuspid valve procedures. $31.4M Series B, $110M Series C (Dec 2024) from Eclipse, Intuitive Ventures. First-in-human trial 2025, pivotal trial 2026.
Key Products & Services
Robotic Mitral Valve System
Industry Sectors
Founded
2020
Employees
50-100
Funding
$150M
Quick Links
Company Details
- Country
- United States
- City
- Santa Cruz
- State
- California
- Type
- commercial